Aravind G. Tamilarasan

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Transmural healing is significantly associated with prevention of clinical relapse in Crohn's disease.

Transmural healing is significantly associated with prevention of clinical relapse in Crohn's disease.

Journal: Inflammatory bowel diseases

Published: September 28, 2025

Genital rash: A manifestation of metastatic Crohn's disease.

Genital rash: A manifestation of metastatic Crohn's disease.

Journal: Clinical case reports

Published: June 20, 2024

Paraneoplastic gastrointestinal dysmotility due to non-Hodgkin diffuse large B cell lymphoma: a case report.

Paraneoplastic gastrointestinal dysmotility due to non-Hodgkin diffuse large B cell lymphoma: a case report.

Journal: European journal of gastroenterology & hepatology

Published: March 13, 2024

Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia.

Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia.

Journal: Expert opinion on biological therapy

Published: April 18, 2023

The diagnostic yield of pan-enteric capsule endoscopy in inflammatory bowel disease: A systematic review and meta-analysis.

The diagnostic yield of pan-enteric capsule endoscopy in inflammatory bowel disease: A systematic review and meta-analysis.

Journal: Journal of gastroenterology and hepatology

Published: July 06, 2022

Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)-A Case Report.

Recurrent Campylobacter jejuni Infection in an Immunodeficient Patient Treated with Repeated Faecal Microbiota Transplant (FMT)-A Case Report.

Journal: Infectious disease reports

Published: December 17, 2021

Faecal microbiota transplantation: what's beyond Clostridium difficile infection?

Faecal microbiota transplantation: what's beyond Clostridium difficile infection?

Journal: European journal of gastroenterology & hepatology

Published: November 12, 2020

Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study.

Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study.

Journal: Alimentary pharmacology & therapeutics

Published: March 20, 2020

Faecal microbiota transplantation for refractory C lostridium difficile infection.

Faecal microbiota transplantation for refractory C lostridium difficile infection.

Journal: BMJ case reports

Published: November 30, 2019

Biologic therapies for Crohn's disease: optimising the old and maximising the new.

Biologic therapies for Crohn's disease: optimising the old and maximising the new.

Journal: F1000Research

Published: July 19, 2019

Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response.

Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response.

Journal: Frontline gastroenterology

Published: May 09, 2019

Positioning biologics and new therapies in the management of inflammatory bowel disease.

Positioning biologics and new therapies in the management of inflammatory bowel disease.

Journal: Current opinion in gastroenterology

Published: April 26, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026